Vaxcyte (PCVX) Profit After Tax (2019 - 2026)
Vaxcyte (PCVX) reported Profit After Tax of -$320.6 million for Q1 2026, down 127.85% year-over-year from $1.2 billion in Q1 2025, and down 30.07% quarter-over-quarter from -$246.5 million in Q4 2025.
Vaxcyte (PCVX) Profit After Tax (2019 - 2026) Analysis & Trends
Vaxcyte (PCVX) has 8 years of Profit After Tax data on file, last reported at -$320.6 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$320.6 million, down 127.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$946.5 million (down 85.73% YoY), and the FY2025 annual result was -$766.6 million, down 65.25% from the prior year.
- Profit After Tax fell to -$320.6 million in Q1 2026 per PCVX's latest filing, from -$246.5 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$39.0 million in Q1 2022 and troughed at -$320.6 million in Q1 2026.
- A 5-year average of -$128.1 million and a median of -$103.1 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2022 and 2024: Profit After Tax slumped 173.26% in 2022, then rose 24.18% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$78.0 million in 2022, then slumped by 131.65% to -$180.8 million in 2023, then gained by 24.18% to -$137.1 million in 2024, then slumped by 79.83% to -$246.5 million in 2025, then plunged by 30.07% to -$320.6 million in 2026.
- Business Quant data shows PCVX's Profit After Tax at -$320.6 million in Q1 2026, -$246.5 million in Q4 2025, and -$212.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -56.74 Mn |
| 10 | Vaxcyte | 6.34 Bn | 6.34 Bn | - | -320.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -320.62 Mn |
| Dec 31, 2025 | -246.51 Mn |
| Sep 30, 2025 | -212.83 Mn |
| Jun 30, 2025 | -166.57 Mn |
| Mar 31, 2025 | -140.72 Mn |
| Dec 31, 2024 | -137.08 Mn |
| Sep 30, 2024 | -103.12 Mn |
| Jun 30, 2024 | -128.70 Mn |
| Mar 31, 2024 | -95.02 Mn |
| Dec 31, 2023 | -180.80 Mn |
| Sep 30, 2023 | -92.66 Mn |
| Jun 30, 2023 | -68.34 Mn |
| Mar 31, 2023 | -60.46 Mn |
| Dec 31, 2022 | -78.05 Mn |
| Sep 30, 2022 | -57.92 Mn |
| Jun 30, 2022 | -48.53 Mn |
| Mar 31, 2022 | -38.99 Mn |
| Dec 31, 2021 | -28.56 Mn |
| Sep 30, 2021 | -26.62 Mn |
| Jun 30, 2021 | -23.68 Mn |